QCM
NVCR icon

Quantinno Capital Management’s NovoCure NVCR Stock Holding History

Quantinno Capital Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.7M Sell
2,223,455
-263,921
-11% -$3.99M 0.04% 514
2026
Q1 		$27.1M Buy
2,487,376
+477,128
+24% +$5.96M 0.05% 505
2025
Q4 		$26M Buy
2,010,248
+488,080
+32% +$6.27M 0.05% 431
2025
Q3 		$19.7M Buy
1,522,168
+153,505
+11% +$2.05M 0.05% 410
2025
Q2 		$24.4M Buy
1,368,663
+380,411
+38% +$6.63M 0.11% 204
2025
Q1 		$17.6M Buy
988,252
+693,613
+235% +$15.8M 0.11% 185
2024
Q4 		$8.78M Buy
294,639
+43,108
+17% +$912K 0.09% 242
2024
Q3 		$3.93M Sell
251,531
-102,925
-29% -$1.87M 0.05% 467
2024
Q2 		$6.07M Buy
354,456
+297,183
+519% +$5.23M 0.11% 177
2024
Q1 		$895K Buy
57,273
+31,831
+125% +$468K 0.02% 770
2023
Q4 		$380K Buy
+25,442
New +$340K 0.01% 896
2021
Q2 		– Sell
-1,693
Closed -$224K – 247
2021
Q1 		$224K Hold
1,693
– – 0.24% 223
2020
Q4 		$293K Sell
1,693
-798
-32% -$109K 0.23% 233
2020
Q3 		$277K Buy
+2,491
New +$199K 0.19% 286
2020
Q2 		– Sell
-5,002
Closed -$337K – 413
2020
Q1 		$337K Buy
+5,002
New +$395K 0.21% 257

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Quantinno Capital Management's NVCR Position: Q2 2026 in Review

Quantinno Capital Management reduced its NovoCure (NVCR) stake by 11% in Q2 2026, selling an estimated $3.99M and leaving 2,223,455 shares worth $33.7M. The position accounts for 0.04% of the portfolio, ranked #514.

Quantinno Capital Management first reported a position in NVCR in Q1 2020 and has held it in 15 quarters since. 216 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Quantinno Capital Management held 2,223,455 shares of NovoCure worth $33.7M as of Q2 2026.
  • Quantinno Capital Management sold 263,921 NovoCure shares in Q2 2026, an estimated $3.99M.
  • NovoCure made up 0.04% of Quantinno Capital Management's portfolio in Q2 2026, its #514 holding.
  • Quantinno Capital Management first reported a position in NovoCure in Q1 2020 and has held it in 15 quarters since.
  • 216 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.